Dr. Tobias Dörr, Member, RIBB-SAB
Tobias Dörr (Doerr) obtained his Master’s degree in Biology from the University of Hannover in Germany. Following his diploma thesis “finding new persister genes”, Dr. Dörr joined Dr. Kim Lewis’ laboratory at Northeastern University in Boston, Massachusetts, where he earned his doctorate with the dissertation “SOS response and the mechanism of adaptive tolerance in Escherichia coli”. Following his PhD research, Dr. Dörr joined the lab of Dr. Matthew Waldor at Harvard Medical School as a postdoc in molecular pathogenesis, working on cell envelope homeostasis in the cholera pathogen Vibrio cholerae. In 2016, Dr. Dörr joined the faculty of Cornell University in New York, where he is now an Associate Professor of Microbiology at the Weill Institute for Cell and Molecular Biology, the Department of Microbiology, and an affiliate of the Cornell Institute of Host-Microbe Interactions and Disease. His laboratory studies molecular mechanisms of bacterial stress responses, infection dynamics, and the molecular basis for cell envelope modifications in Gram-negative pathogens.
Prof. Harald Gross, Member, RIBB-SAB
Harald Gross is a pharmacist by training and dealt during his PhD studies in Bonn/Germany and subsequent 2-years PostDoc stay in the USA with ´Drugs from the Sea´, i.e. marine natural product chemistry of marine sponges, soft corals and algae. Back at the University of Bonn, he established in 2006 his own independent research group and focused on the genomics and secondary metabolism of Pseudomonas bacteria. In 2012 he was appointed Full Professor for Pharmaceutical Biology at the University of Tuebingen. His research interests are in the field of genome-driven discovery of microbial secondary metabolites, biosynthesis research and genetic engineering.